Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Xin Fan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8774-4787; OpenAlex author ID A5100650319. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 9

  1. A Noncanonical Hedgehog Signaling Exerts a Tumor-Promoting Effect on Pancreatic Cancer Cells Via Induction of Osteopontin Expression. Co-author DOI 10.1089/cbr.2021.0317↗
  2. Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness. Co-author DOI 10.1038/s41419-019-1956-8↗
  3. Krüppel-like factor 9 suppressed tumorigenicity of the pancreatic ductal adenocarcinoma by negatively regulating frizzled-5. First author DOI 10.1016/j.bbrc.2018.03.229↗
  4. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling. Co-author DOI 10.18632/oncotarget.15633↗
  5. KLF9 Is a Prognostic Indicator in Human Pancreatic Ductal Adenocarcinoma. First author DOI 10.21873/anticanres.11756↗
  6. Secreted protein acidic and rich in cysteine enhances the chemosensitivity of pancreatic cancer cells to gemcitabine. Co-author DOI 10.1007/s13277-015-4044-4↗
  7. Cyclooxygenase 2 promoted the tumorigenecity of pancreatic cancer cells. Co-author DOI 10.1007/s13277-013-1301-2↗
  8. Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction. Co-author DOI 10.1007/s13277-014-2315-0↗
  9. CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer. Co-author DOI 10.1007/s13277-012-0434-z↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengfa Mao · 6 shared papers, 2012–2018 · strength 0.36
  2. Xu‐Qing Wang · 6 shared papers, 2012–2018 · strength 0.36
  3. Weijiang Wu · 1 shared paper, 2026 · strength 0.28
  4. Qixiang Shao · 1 shared paper, 2026 · strength 0.28
  5. Jianxin Zhang · 4 shared papers, 2014–2018 · strength 0.28
  6. Lei Cui · 3 shared papers, 2014–2016 · strength 0.16
  7. Peiyu Ji · 1 shared paper, 2018 · strength 0.10
  8. Lirong Zhang · 1 shared paper, 2019 · strength 0.09
  9. Aihua Gong · 1 shared paper, 2019 · strength 0.09
  10. Hongbo Chen · 1 shared paper, 2019 · strength 0.09
  11. Yanfang Liu · 1 shared paper, 2019 · strength 0.09
  12. Haitao Zhu · 1 shared paper, 2019 · strength 0.09
  13. Yong Zhang · 1 shared paper, 2017 · strength 0.08
  14. Christoph W. Michalski · 1 shared paper, 2017 · strength 0.08
  15. Chen Jixiang · 1 shared paper, 2017 · strength 0.07
  16. Cui Lei · 1 shared paper, 2017 · strength 0.07
  17. Sheng-Chun Dang · 1 shared paper, 2016 · strength 0.06
  18. Wenjun Li · 1 shared paper, 2014 · strength 0.06
  19. Jianxin Zhang · 1 shared paper, 2012 · strength 0.03
  20. Lei Cui · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.